Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/29/2025

Hepatotoxicity of Common Medications

Introduction to Hepatotoxic Drugs

  • Acetaminophen, isoniazid, rifampin, and pyrazinamide are among the most common hepatotoxic drugs that can cause significant liver injury, with acetaminophen being the leading cause of drug-induced liver failure in the United States 1

First-Line Antituberculosis Drugs

  • Isoniazid (INH), rifampin (RIF), and pyrazinamide (PZA) are first-line antituberculosis drugs that can cause drug-induced liver injury (DILI) 2, 3
  • Among first-line agents for tuberculosis treatment, pyrazinamide is considered the most hepatotoxic 4

Analgesics and Anti-inflammatory Drugs

  • Acetaminophen is the most common cause of drug-induced liver failure and can cause fulminant hepatic failure, especially at doses exceeding 4g per day 5
  • Even at therapeutic doses, acetaminophen can cause hepatotoxicity in chronic alcohol users 5
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) are responsible for approximately 10% of drug-induced hepatitis cases 5
  • NSAIDs can cause increased side effects and toxicity in patients with liver disease due to higher concentrations of free compounds 5

Risk Factors for Drug-Induced Liver Injury

  • Excessive alcohol consumption, even if discontinued during treatment, increases the risk of drug-induced liver injury 4
  • Underlying liver disease predisposes patients to drug-induced hepatotoxicity 4
  • Previous history of drug-induced liver injury increases the risk of recurrence with re-exposure to the same or similar drugs 4

Monitoring and Management

  • Drug-induced hepatitis is suspected when ALT levels are ≥3 times the upper limit of normal with hepatitis symptoms, or ≥5 times the upper limit of normal without symptoms 2, 6
  • When hepatotoxicity is suspected, the offending drugs should be stopped immediately and the patient carefully evaluated 2, 6
  • Baseline and regular monitoring of liver function is required in patients with known chronic liver disease who are taking potentially hepatotoxic medications 7

Special Considerations

  • In patients with liver cirrhosis, acetaminophen at doses of 2-3g per day is generally recommended instead of the standard 4g maximum 5
  • Patients with liver disease should avoid NSAIDs as much as possible due to increased risk of side effects including hepatotoxicity, nephrotoxicity, and gastric ulcers 5